Cell-based therapies are widely used to treat blood cancer, but Stanford Medicine recently became the first in the nation to use the same method to treat solid tumors.
Stanford Medicine researchers are working to get the latest diabetes management technology into the hands of every patient, and make it easier for providers to flag those who need help.
Stanford Medicine researchers are developing artificial intelligence tools that provide a more accurate picture of a person’s mental health and flag those who need help.
A Stanford Medicine-led effort to map the molecular changes linked to exercise and health offers the broadest picture yet of why, in the health arena, sweat is king.
When the brain has trouble filtering incoming information and predicting what’s likely to happen, psychosis can result, Stanford Medicine-led research shows.
Some of the 17 million Americans afflicted with major depressive disorder may soon receive a surprising prescription from their clinician: Have fun on a VR device.
By creating recipes for drugs that target antibiotic-resistant bacteria, a new model is teaching scientists about “a chemical space humans just haven’t explored before.”
A small clinical trial found that a ketogenic diet helped offset the metabolic side effects of antipsychotic drugs used to treat patients with schizophrenia and bipolar disorder.
Researchers say the lingering symptoms are often misdiagnosed by doctors and dismissed by employers or loved ones. The results can be devastating for patients and the economy.
A medication commonly prescribed to control blood sugar levels stimulates the appetite-suppressing molecule produced after exercise, new research finds.
On Match Day, the School of Medicine Class of ’24 opened the envelopes that would tell them where they would complete the final phase of their training.
Despite common lore about major lapses in memory, the effects of healthy aging on cognitive functions are actually quite subtle, says Stanford neurologist Sharon Sha.
The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant variants.
New research suggests that public health strategies to increase vaccinations should focus on those over 65 and the immunocompromised, who benefit the most from frequent boosters.
